Effect and mechanism of Bufei Huoxue Capsule on the intervention of chronic inflammation and mucus hypersecretion in the airways of rats with chronic obstructive pulmonary disease

MENG Yufeng; WANG Chengxiang; SHI Liangtian; ZHAO Jingjun; FENG Cuiling

doi:10.16025/j.1674-1307.2024.04.003

您当前的位置：

首页 >

文章列表页 >

Effect and mechanism of Bufei Huoxue Capsule on the intervention of chronic inflammation and mucus hypersecretion in the airways of rats with chronic obstructive pulmonary disease

更新时间：2024-06-03

- Effect and mechanism of Bufei Huoxue Capsule on the intervention of chronic inflammation and mucus hypersecretion in the airways of rats with chronic obstructive pulmonary disease
- Beijing Journal of Traditional Chinese Medicine Vol. 43, Issue 4, Pages: 352-358(2024)
- 作者机构：
  
  1.北京中医药大学第三附属医院，北京 100029
  2.北京大学人民医院，北京 100044
- 作者简介：
- 基金信息：
- DOI：10.16025/j.1674-1307.2024.04.003
  CLC：
- Published：25 April 2024，
  
  Received：05 March 2024，
扫描看全文
孟玉凤，王成祥，史良恬，等.补肺活血胶囊干预慢性阻塞性肺疾病大鼠模型气道炎症及黏液高分泌的作用及机制研究［J］.北京中医药，2024，43（4）：352-358.

MENG Yufeng,WANG Chengxiang,SHI Liangtian,et al.Effect and mechanism of Bufei Huoxue Capsule on the intervention of chronic inflammation and mucus hypersecretion in the airways of rats with chronic obstructive pulmonary disease[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):352-358.
孟玉凤，王成祥，史良恬，等.补肺活血胶囊干预慢性阻塞性肺疾病大鼠模型气道炎症及黏液高分泌的作用及机制研究［J］.北京中医药，2024，43（4）：352-358. DOI： 10.16025/j.1674-1307.2024.04.003.

MENG Yufeng,WANG Chengxiang,SHI Liangtian,et al.Effect and mechanism of Bufei Huoxue Capsule on the intervention of chronic inflammation and mucus hypersecretion in the airways of rats with chronic obstructive pulmonary disease[J]. Beijing Journal of Traditional Chinese Medicine,2024,43(04):352-358. DOI： 10.16025/j.1674-1307.2024.04.003.

摘要

目的

研究补肺活血胶囊对慢性阻塞性肺疾病（简称“慢阻肺”）大鼠模型气道炎症及黏液高分泌的干预作用和机制。

方法

采用烟熏并气道内滴注脂多糖的方法制备慢阻肺大鼠模型。40只Wistar大鼠随机分为空白对照组、模型组、补肺活血组和茶碱组，空白对照组及模型组予以生理盐水灌胃，补肺活血组和茶碱组分别予补肺活血胶囊和茶碱缓释片溶液灌胃。使用小动物肺功能仪检测大鼠肺功能，苏木精-伊红染色和阿利新蓝-过碘雪芙染色进行形态学分析，酶联免疫吸附实验检测肺泡灌洗液中IL-1β、IL-6、NE、TGF-β、EGF、IL-13和TNF-α的表达，免疫组化法检测大鼠肺组织中黏蛋白5AC（Muc5ac）的表达，免疫印迹法检测Toll样受体4（TLR4）、髓样分化初级应答基因88（MyD88）、NF-κB、Muc5ac、EGFR/p-EGFR、PI3K/p-PI3K、AKT/p-AKT的蛋白表达。

结果

补肺活血胶囊能够改善慢阻肺模型大鼠FVC、FEV

0.3

、FEV

0.3

/FVC和FEF25-75（

0.05，

0.01），显著降低肺泡灌洗液中IL-1β、IL-6、NE、TGF-β、EGF、IL-13和 TNF-α的含量（

0.05，

0.01），减少TLR4、M

yD88、ERK1/2、P38MAPK、NF-κB、Muc5ac、p-EGFR、p-PI3K和p-AKT蛋白的表达（

0.05，

0.01）。

结论

补肺活血胶囊可能通过抑制慢阻肺大鼠模型气道炎症及黏液高分泌改善肺功能。

Abstract

Objective

To investigate the intervention effect and mechanism of Bufei Huoxue Capsule on airway inflammation and mucus hypersecretion in rats with chronic obstructive pulmonary disease （COPD） .

Methods

The rat model of COPD was established by smoking and intratracheal instillation of lipopolysaccharide . The lung function was measured by small animal lung function meter， and the morphology of airway epithelial cells was detected by hematoxylin-eosinstaining and alicinblue-periodopho staining， the expressions of IL-1β， IL-6， NE， TGF-β， EGF， IL-13 and TNF-α in BALF were detected by enzyme-linked immunosorbent assay ， the protein expressions of TLR4， Myd88， NF-κB， Muc5ac， EGFR/p-EGFR， PI3K/p-PI3K， Akt/p-AKT were detected by Western-blot， and the expression of Muc5ac was detected by immunohistochemistry.

Results

Bufei Huoxue Capsule could improve FVC， FEV

0.3

， FEV

0.3

/FVC and FEF25-75 in rats with chronic obstructive pulmonary disease （

0.05，

0.01） reduce the contents of IL-1β， IL-6， NE， TGF- β， EGF， IL-13 and TNF- α significantly （

0.05，

0.01）； the protein expressions of TLR4， MyD88， ERK1/2， P38MAPK， NF-κB， Muc5ac， p-EGFR， p-PI3K and p-AKT were decreased.（

0.05，

0.01）.

Conclusion

Bufei Huoxue Capsule can improve lung injury by inhibiting airway inflammation and mucus hypersecretion in rats with COPD.

关键词

补肺活血胶囊慢性阻塞性肺疾病慢性炎症气道黏液高分泌

Keywords

Bufei Huoxue Capsulechronic obstructive pulmonary diseasechronic inflammationairway mucus hypersecretion

references

AGUSTÍ A, CELLI BR,CRINER GJ,et al.Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary[J].Am J Respir Crit Care Med，2023,207(7):819-837.

STRZELAK A, RATAJCZAK A, ADAMIEC A, et al. Tobacco smoke induces and alters immune responses in the lung triggering inflammation, Allergy, Asthma and other lung diseases: A mechanistic review[J]. Int J Environ Res Public Health, 2018,15(5)：1033.

FANG LW, GAO P, BAO HL, et al. Chronic obstructive pulmonary disease in China: a nationwide prevalence study[J]. Lancet Resp Med, 2018,6(6):421-430.

敬岳, 张洪春, 金津,等. 补肺活血中药对慢性阻塞性肺疾病小鼠肺功能及炎症反应的影响[J]. 北京中医药,2023,42(3):281-284.

刘治坤, 张前, 李宝萍,等. 芪蛭益肺颗粒对慢性阻塞性肺疾病模型大鼠小气道上皮MMP-9、TIMP-1表达的影响[J]. 北京中医药大学学报,2013,36(5):322-326,后插2.

XIANG W, CHAO ZY, FENG DY. Role of toll-like receptor/MYD88 signaling in neurodegenerative diseases[J]. Rev Neurosci, 2015,26(4):407-414.

KAWAI T, AKIRA S. TLR signaling[J]. Semin Immunol,2007,19(1):24-32.

KAWAI T, AKIRA S. Toll-like receptors and their crosstalk with other innate receptors in infection and immunity[J]. Immunity, 2011,34(5):637-650.

岳梦佳, 左之才, 阳明贤,等. 抵抗素通过TLR4/MyD88依赖途径促进牛肺泡巨噬细胞炎症因子产生[J]. 中国免疫学杂志,2019,35(19):2305-2309.

ROVINA N, KOUTSOUKOU A, KOULOURIS NG. Inflammation and immune response in COPD: where do we stand[J]. Mediators Inflamm,2013:413735.

LRAMOS F, KRAHNKE JS, KIM V. Clinical issues of mucus accumulation in COPD[J]. Int J Chron Obstruct Pulmon Dis, 2014,9:139-150.

LI J, YE Z. The potential role and regulatory mechanisms of MUC5AC in chronic obstructive pulmonary disease[J]. Molecules,2020,25(19): 4437.

WANG Y. Effects of doxofylline combined with ceftazidime on clinical efficacy, drug safety, and prognosis in patients with chronic obstructive pulmonary disease complicated with infection [J]. Med Sci Monit,2021,27:e930494.

吴佳, 尧雪洲. 在慢阻肺炎症反应中黄芪多糖的抗炎作用及抑制TLR4/NF-κB通路的机制[J]. 西安交通大学学报（医学版）,2018,39(5):760-764.

徐飞, 林锦培, 李璐璐,等. 赤芍对慢性阻塞性肺疾病大鼠气道重塑的影响及机制研究[J]. 中华中医药杂志,2017,32(4):1755-1760.

HUNG YL, FANG SH, WANG SC, et al. Corylin protects LPS-induced sepsis and attenuates LPS-induced inflammatory response[J]. Sci Rep,2017,7:46299.

TANG Y, CAI QH, WANG YJ, et al. Protective effect of autophagy on endoplasmic reticulum stress induced apoptosis of alveolar epithelial cells in rat models of COPD[J]. Biosci Rep, 2017,37(6)：1152-1166.

MEN WJ, CHENG LY, CHEN MY, et al. Study on pharmacokinetics of eight active compounds from Bufei-Huoxue Capsule based on UHPLC-MS/MS[J]. J Chromatogr B Analyt Technol Biomed Life Sci,2021,9(1) :122974.

任慧, 郭盛, 张祎盈,等. UHPLC-MS/MS测定补肺活血胶囊中8种有效成分在大鼠体内血药浓度及药代动力学研究[J]. 中国中药杂志,2022,47(1):215-223.

闫守霞, 许石钟, 关爱阁. 补肺活血胶囊对慢性阻塞性肺疾病患者肺功能及血清GM-CSF、NF-κB、 LT-B4的影响[J]. 亚太传统医药,2020,16(2):140-142.

夏文娟, 梅晓冬, 王学中. 补肺活血胶囊联合阿奇霉素片治疗COPD稳定期患者的临床观察[J]. 中国药房,2019,30(10):1403-1406.

Views

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Clinical observation of Feixin'an a self-made Chinese medicine formula in treating 30 cases of chronic obstructive pulmonary disease of deficiency of qi and yin in stable stage

Related Author

Zhen-yu DONG

Rui CAO

Wen-quan LI

Hong QUAN

Related Institution

Department of Traditional Chinese medicine，Beijing Chaoyang Hospital Affiliated to the Capital Medical University

⁰